JPH0716426B2 - Method for producing phospholipid by enzyme - Google Patents
Method for producing phospholipid by enzymeInfo
- Publication number
- JPH0716426B2 JPH0716426B2 JP18002586A JP18002586A JPH0716426B2 JP H0716426 B2 JPH0716426 B2 JP H0716426B2 JP 18002586 A JP18002586 A JP 18002586A JP 18002586 A JP18002586 A JP 18002586A JP H0716426 B2 JPH0716426 B2 JP H0716426B2
- Authority
- JP
- Japan
- Prior art keywords
- phospholipid
- reaction
- dissolved
- phospholipase
- enzyme
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 150000003904 phospholipids Chemical class 0.000 title claims description 47
- 102000004190 Enzymes Human genes 0.000 title claims description 16
- 108090000790 Enzymes Proteins 0.000 title claims description 16
- 238000004519 manufacturing process Methods 0.000 title claims description 11
- 238000006243 chemical reaction Methods 0.000 claims description 24
- 239000000693 micelle Substances 0.000 claims description 23
- 102000011420 Phospholipase D Human genes 0.000 claims description 20
- 108090000553 Phospholipase D Proteins 0.000 claims description 20
- 239000002994 raw material Substances 0.000 claims description 14
- 239000008346 aqueous phase Substances 0.000 claims description 11
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 10
- 239000004094 surface-active agent Substances 0.000 claims description 7
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 claims description 6
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims description 5
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims description 5
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims description 5
- 239000003960 organic solvent Substances 0.000 claims description 5
- HXKKHQJGJAFBHI-UHFFFAOYSA-N 1-aminopropan-2-ol Chemical compound CC(O)CN HXKKHQJGJAFBHI-UHFFFAOYSA-N 0.000 claims description 3
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 2
- 125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 claims 1
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 22
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 21
- 239000003153 chemical reaction reagent Substances 0.000 description 13
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 238000004809 thin layer chromatography Methods 0.000 description 12
- 238000000034 method Methods 0.000 description 11
- 125000001095 phosphatidyl group Chemical group 0.000 description 11
- 239000000047 product Substances 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 239000011541 reaction mixture Substances 0.000 description 10
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 9
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- 240000007124 Brassica oleracea Species 0.000 description 8
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 8
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 8
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 8
- 239000008351 acetate buffer Substances 0.000 description 8
- 239000012074 organic phase Substances 0.000 description 8
- 239000000243 solution Substances 0.000 description 7
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 150000001450 anions Chemical class 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 6
- 239000000758 substrate Substances 0.000 description 6
- 238000006276 transfer reaction Methods 0.000 description 6
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 5
- PORPENFLTBBHSG-MGBGTMOVSA-N 1,2-dihexadecanoyl-sn-glycerol-3-phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(O)=O)OC(=O)CCCCCCCCCCCCCCC PORPENFLTBBHSG-MGBGTMOVSA-N 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- GUBGYTABKSRVRQ-WFVLMXAXSA-N DEAE-cellulose Chemical compound OC1C(O)C(O)C(CO)O[C@H]1O[C@@H]1C(CO)OC(O)C(O)C1O GUBGYTABKSRVRQ-WFVLMXAXSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- NHTMVDHEPJAVLT-UHFFFAOYSA-N Isooctane Chemical compound CC(C)CC(C)(C)C NHTMVDHEPJAVLT-UHFFFAOYSA-N 0.000 description 4
- 150000001768 cations Chemical class 0.000 description 4
- JVSWJIKNEAIKJW-UHFFFAOYSA-N dimethyl-hexane Natural products CCCCCC(C)C JVSWJIKNEAIKJW-UHFFFAOYSA-N 0.000 description 4
- 238000005194 fractionation Methods 0.000 description 4
- 238000006460 hydrolysis reaction Methods 0.000 description 4
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 4
- FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 description 4
- 239000012071 phase Substances 0.000 description 4
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 3
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 3
- 235000010469 Glycine max Nutrition 0.000 description 3
- 244000068988 Glycine max Species 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 229960002713 calcium chloride Drugs 0.000 description 3
- 239000001110 calcium chloride Substances 0.000 description 3
- 229910001628 calcium chloride Inorganic materials 0.000 description 3
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 235000019329 dioctyl sodium sulphosuccinate Nutrition 0.000 description 3
- YHAIUSTWZPMYGG-UHFFFAOYSA-L disodium;2,2-dioctyl-3-sulfobutanedioate Chemical compound [Na+].[Na+].CCCCCCCCC(C([O-])=O)(C(C([O-])=O)S(O)(=O)=O)CCCCCCCC YHAIUSTWZPMYGG-UHFFFAOYSA-L 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 229960001153 serine Drugs 0.000 description 3
- 159000000000 sodium salts Chemical class 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- JQWAHKMIYCERGA-UHFFFAOYSA-N (2-nonanoyloxy-3-octadeca-9,12-dienoyloxypropoxy)-[2-(trimethylazaniumyl)ethyl]phosphinate Chemical compound CCCCCCCCC(=O)OC(COP([O-])(=O)CC[N+](C)(C)C)COC(=O)CCCCCCCC=CCC=CCCCCC JQWAHKMIYCERGA-UHFFFAOYSA-N 0.000 description 2
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 125000002252 acyl group Chemical group 0.000 description 2
- 125000003158 alcohol group Chemical group 0.000 description 2
- RJGDLRCDCYRQOQ-UHFFFAOYSA-N anthrone Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3CC2=C1 RJGDLRCDCYRQOQ-UHFFFAOYSA-N 0.000 description 2
- LLSDKQJKOVVTOJ-UHFFFAOYSA-L calcium chloride dihydrate Chemical compound O.O.[Cl-].[Cl-].[Ca+2] LLSDKQJKOVVTOJ-UHFFFAOYSA-L 0.000 description 2
- 229940052299 calcium chloride dihydrate Drugs 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 239000007810 chemical reaction solvent Substances 0.000 description 2
- SIHHLZPXQLFPMC-UHFFFAOYSA-N chloroform;methanol;hydrate Chemical compound O.OC.ClC(Cl)Cl SIHHLZPXQLFPMC-UHFFFAOYSA-N 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 150000004683 dihydrates Chemical class 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 229930182478 glucoside Natural products 0.000 description 2
- 150000008131 glucosides Chemical class 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 238000004949 mass spectrometry Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 230000009257 reactivity Effects 0.000 description 2
- 150000003333 secondary alcohols Chemical class 0.000 description 2
- APSBXTVYXVQYAB-UHFFFAOYSA-M sodium docusate Chemical compound [Na+].CCCCC(CC)COC(=O)CC(S([O-])(=O)=O)C(=O)OCC(CC)CCCC APSBXTVYXVQYAB-UHFFFAOYSA-M 0.000 description 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 2
- 229940083466 soybean lecithin Drugs 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- HOVAGTYPODGVJG-UVSYOFPXSA-N (3s,5r)-2-(hydroxymethyl)-6-methoxyoxane-3,4,5-triol Chemical compound COC1OC(CO)[C@@H](O)C(O)[C@H]1O HOVAGTYPODGVJG-UVSYOFPXSA-N 0.000 description 1
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 1
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 description 1
- DKPQIOQEAATZQU-UHFFFAOYSA-N 1,4-dioctoxy-1,4-dioxobutane-2-sulfonic acid;sodium Chemical compound [Na].[Na].CCCCCCCCOC(=O)CC(S(O)(=O)=O)C(=O)OCCCCCCCC DKPQIOQEAATZQU-UHFFFAOYSA-N 0.000 description 1
- CFWRDBDJAOHXSH-SECBINFHSA-N 2-azaniumylethyl [(2r)-2,3-diacetyloxypropyl] phosphate Chemical compound CC(=O)OC[C@@H](OC(C)=O)COP(O)(=O)OCCN CFWRDBDJAOHXSH-SECBINFHSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 239000000592 Artificial Cell Substances 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 description 1
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 description 1
- 102000004157 Hydrolases Human genes 0.000 description 1
- 108090000604 Hydrolases Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- YGRUUPPVGMDKDK-UHFFFAOYSA-N O.OC.CC(C)=O.CC(O)=O.ClC(Cl)Cl Chemical compound O.OC.CC(C)=O.CC(O)=O.ClC(Cl)Cl YGRUUPPVGMDKDK-UHFFFAOYSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- ATBOMIWRCZXYSZ-XZBBILGWSA-N [1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-hexadecanoyloxypropan-2-yl] (9e,12e)-octadeca-9,12-dienoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(COP(O)(=O)OCC(O)CO)OC(=O)CCCCCCC\C=C\C\C=C\CCCCC ATBOMIWRCZXYSZ-XZBBILGWSA-N 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000002473 artificial blood Substances 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- NPAGFLVMYDKFJH-UHFFFAOYSA-N dichloromethane;2,2,4-trimethylpentane Chemical compound ClCCl.CC(C)CC(C)(C)C NPAGFLVMYDKFJH-UHFFFAOYSA-N 0.000 description 1
- YWEUIGNSBFLMFL-UHFFFAOYSA-N diphosphonate Chemical compound O=P(=O)OP(=O)=O YWEUIGNSBFLMFL-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000000752 ionisation method Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- CXALKVCCFXJRKT-UHFFFAOYSA-N methanol;propan-2-ol;hydrate Chemical compound O.OC.CC(C)O CXALKVCCFXJRKT-UHFFFAOYSA-N 0.000 description 1
- HOVAGTYPODGVJG-UHFFFAOYSA-N methyl beta-galactoside Natural products COC1OC(CO)C(O)C(O)C1O HOVAGTYPODGVJG-UHFFFAOYSA-N 0.000 description 1
- 239000004530 micro-emulsion Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 1
- 150000008104 phosphatidylethanolamines Chemical class 0.000 description 1
- 150000003905 phosphatidylinositols Chemical class 0.000 description 1
- DLYUQMMRRRQYAE-UHFFFAOYSA-N phosphorus pentoxide Inorganic materials O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- -1 polyoxyethylene nonylphenyl ether Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000012746 preparative thin layer chromatography Methods 0.000 description 1
- 125000000075 primary alcohol group Chemical group 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000013094 purity test Methods 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- RCIJACVHOIKRAP-UHFFFAOYSA-M sodium;1,4-dioctoxy-1,4-dioxobutane-2-sulfonate Chemical compound [Na+].CCCCCCCCOC(=O)CC(S([O-])(=O)=O)C(=O)OCCCCCCCC RCIJACVHOIKRAP-UHFFFAOYSA-M 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Description
【発明の詳細な説明】 (産業上の利用分野) 本発明は、酵素によるリン脂質の製造方法に関し、特
に、塩基構造が変換されたリン脂質を製造する方法に関
する。TECHNICAL FIELD The present invention relates to a method for producing a phospholipid by an enzyme, and particularly to a method for producing a phospholipid having a converted base structure.
(従来の技術) リン脂質は、単に乳化剤に用い得るのみならずリポソー
ムの基材として薬剤運搬体、人工血液、人工細胞等への
応用が近年注目されており、また、それ自体生理活性・
薬理作用を持つものとして、医学・薬学・工学的分野の
様々な用途が考えられている。このような多様な要求に
対応するために、各々の用途に応じた構造を有するリン
脂質を効率的に製造する方法を開発することは、産業上
非常に意義のあることである。(Prior art) Phospholipids are not only used as emulsifiers, but in recent years, their application to drug carriers, artificial blood, artificial cells, etc. as a base material for liposomes has been attracting attention, and their own physiological activity
Various applications in the fields of medicine, pharmacy, and engineering are considered as those having a pharmacological action. In order to meet such various demands, it is industrially significant to develop a method for efficiently producing a phospholipid having a structure suitable for each application.
酵素によるリン脂質の製造方法として、リン脂質にホス
ホリパーゼDを任意の受容体に存在下に作用させ、ホス
ファチジル基転移反応を利用して目的とする塩基を持つ
リン脂質を製造する技術は公知である〔S.F.Yang,et a
l.,J.Biol.Chem.,242,(3) 477〜484(1967)〕:
〔R.M.C.Dawson,Biochem.J.,102,205〜210(1967)〕。As a method for producing a phospholipid by an enzyme, a technique is known in which phospholipase D is allowed to act on a phospholipid in the presence of an arbitrary receptor and a phospholipid having a desired base is produced by utilizing a phosphatidyl group transfer reaction. (SF Yang, et a
L., J. Biol. Chem., 242, (3) 477-484 (1967)]:
[RMC Dawson, Biochem. J., 102, 205-210 (1967)].
ホスホリパーゼDによるホスファチジル基転移反応を利
用してリン脂質の塩基部分を交換しようとする場合、一
般に水相と有機溶媒相との二相系が用いられる。すなわ
ち、主として水溶性である酵素、受容体、pH緩衝液、無
機塩等を含む水溶液と、主として親油性である原料リン
脂質を含む有機溶媒相とを撹拌・混合する反応系であ
る。前出の技術をはじめ、その後の研究〔K.Bruzik and
M.Tsai,Biochemistry23,(8)1656−1661(1984)な
ど〕においても広く用いられている。When the phosphatidyl group transfer reaction by phospholipase D is used to exchange the base portion of phospholipid, a two-phase system of an aqueous phase and an organic solvent phase is generally used. That is, it is a reaction system in which an aqueous solution mainly containing a water-soluble enzyme, a receptor, a pH buffer solution, an inorganic salt and the like and an organic solvent phase mainly containing a lipophilic raw material phospholipid are stirred and mixed. Starting with the above-mentioned technology, subsequent research [K. Bruzik and
M. Tsai, Biochemistry 23 , (8) 1656-1661 (1984)].
(発明が解決しようとする問題点) しかし、従来用いられていたこのような反応系は、水溶
性成分の溶媒としての多量の水の存在が原因となり、ホ
スホリパーゼDが本質的に加水分解活性を持っているた
めに、副反応として加水分解が起こり、ホスファチジン
酸(以下PAと略す)を生成するという欠点を有してい
る。(Problems to be solved by the invention) However, such a reaction system that has been conventionally used is caused by the presence of a large amount of water as a solvent of a water-soluble component, and phospholipase D has essentially no hydrolytic activity. Therefore, it has a drawback that hydrolysis occurs as a side reaction to form phosphatidic acid (hereinafter abbreviated as PA).
加水分解によるPAの生成は、反応後の目的リン脂質の分
離精製を困難にするばかりでなく、加水分解反応によっ
ても原料リン脂質が消費されるため、糖や二級アルコー
ル等の反応性の低い受容体に対してホスファチジル基を
転移させようとする場合、その反応速度が加水分解の反
応速度に対して極端に低いために事実上目的生成物を得
ることができなかった。The production of PA by hydrolysis not only makes it difficult to separate and purify the target phospholipid after the reaction, but also consumes the raw material phospholipid by the hydrolysis reaction, so that the reactivity of sugars and secondary alcohols is low. When trying to transfer the phosphatidyl group to the acceptor, it was virtually impossible to obtain the desired product because the reaction rate was extremely low relative to the hydrolysis reaction rate.
このような問題点は、ホスホリパーゼD自体が本来加水
分解酵素である以上、水が存在する限り不可避である。Such a problem is unavoidable in the presence of water as long as phospholipase D itself is a hydrolase.
そこで、本発明者らは、反応系中の水分含量を酵素が失
活しない範囲で極限まで減少させることによりこの問題
を解決すべく、種々検討の結果、従来二相系の水相とし
て反応系に添加していた成分を、逆ミセル(w/o型マイ
クロエマルション)中に封入して添加する新規な反応系
を考案し、本発明に至ったものである。Therefore, the inventors of the present invention have conducted various investigations in order to solve this problem by reducing the water content in the reaction system to the limit within the range where the enzyme is not inactivated. The present invention was accomplished by devising a new reaction system in which the components added to the above were encapsulated in reverse micelles (w / o type microemulsion) and added.
本明細書において、逆ミセルとは、低極性溶媒中で両親
媒性分子が親油性基を外側に、親水性基を内側に向けて
極微量の水相を中心として会合した状態をいう。In the present specification, the reverse micelle refers to a state in which an amphipathic molecule is associated in a low-polarity solvent with a lipophilic group facing outward and a hydrophilic group facing inward with a very small amount of an aqueous phase as a center.
(問題点を解決するための手段) 本発明は原料リン脂質を溶解した有機溶媒中に、水酸基
を持つ受容体およびホスホリパーゼDを含む水相を逆ミ
セル中に封入した形態で添加して反応を行うことを特徴
とする。(Means for Solving Problems) In the present invention, the reaction is performed by adding an aqueous phase containing a receptor having a hydroxyl group and phospholipase D in a reverse micelle in an organic solvent in which a raw material phospholipid is dissolved. It is characterized by performing.
本発明において用いられる原料リン脂質としては、ホス
ホリパーゼDの基質となり得るものであれば、天然から
抽出したもの、または抽出後精製したもの、あるいは合
成したものを問わず使用できる。また、市販のものある
いは公知の方法で調製したものを使用しても差し支えな
い。As the raw material phospholipid used in the present invention, any material that can be a substrate for phospholipase D can be used regardless of whether it is extracted from nature, purified after extraction, or synthesized. In addition, a commercially available product or a product prepared by a known method may be used.
例として脱脂大豆レシチン、卵黄レシチン、ホスファチ
ジルコリン(以下PCと略す)、ホスファチジルエタノー
ルアミン(以下PEと略す)、ホファチジルセリン(以下
PSと略す)、ホスファチジルグリセロール(以下PGと略
す)等またはそれらの混合物等があげられる。本発明の
効果を最大に発揮するためには、原料リン脂質として精
製したものないしは組成の単純なものを用いた方が反応
生成物の精製の面で都合が良い。また、原料コストと入
手の容易さ、酵素に対する反応性の面から特にPC、PEま
たはPSが工業的に効果が高く好ましい。Examples include defatted soybean lecithin, egg yolk lecithin, phosphatidylcholine (hereinafter abbreviated as PC), phosphatidylethanolamine (hereinafter abbreviated as PE), phosphatidylserine (hereinafter abbreviated as PE).
Examples thereof include PS) and phosphatidylglycerol (hereinafter abbreviated as PG), etc., or a mixture thereof. In order to maximize the effect of the present invention, it is more convenient in terms of purification of the reaction product to use purified phospholipid as a raw material or one having a simple composition. Further, PC, PE or PS is particularly preferable because it is industrially effective from the viewpoints of raw material cost, availability, and reactivity with enzymes.
逆ミセルは界面活性剤により形成することが好ましい。The reverse micelle is preferably formed by a surfactant.
原料リン脂質の大部分が、炭素鎖長12以上のアシル基二
本を有するPC、PE、PGまたはPSまたはこれらの混合物で
ある場合、原料リン脂質自身が逆ミセルを形成するため
の界面活性剤としての作用をする。しかし、原料リン脂
質が炭素鎖長10以下のアシル基二本を有するPC、PE、P
S、PGまたはリゾPC、リゾPE、リゾPS、リゾPGの場合の
ように、原料リン脂質自体では逆ミセルを形成し難い場
合には、下記の条件を満たす界面活性剤を別に添加する
ことが好ましい。When most of the raw material phospholipid is PC, PE, PG or PS having two acyl groups having a carbon chain length of 12 or more, or a mixture thereof, the raw material phospholipid itself is a surfactant for forming reverse micelles. Acts as. However, the raw phospholipid has PC, PE, P having two acyl groups with carbon chain length of 10 or less.
When it is difficult to form reverse micelles with the raw phospholipid itself as in the case of S, PG or lyso PC, lyso PE, lyso PS, lyso PG, a surfactant that satisfies the following conditions may be added separately. preferable.
(a)反応溶媒中に臨界ミセル濃度以上の濃度で溶解し
得る。(A) It can be dissolved in the reaction solvent at a concentration equal to or higher than the critical micelle concentration.
(b)逆ミセルを形成し得る。(B) Reverse micelles can be formed.
(c)酵素活性に決定的な損失を与えない。(C) It does not give a decisive loss in enzyme activity.
(d)アルコール残基を持たないことが望ましい。(D) It is desirable to have no alcohol residue.
例として、ラウリル硫酸ナトリウム、ジ(2−エチルヘ
キシル)スルホコハク酸ナトリウム、ジn−オクチルス
ルホコハク酸ナトリウム、ポリオキシエチレンノニルフ
ェニルエーテル等があげられる。これら界面活性剤の添
加量は、原料リン脂質1モルに対して0.5〜5モルで、
好ましくは1〜3モルである。Examples include sodium lauryl sulfate, sodium di (2-ethylhexyl) sulfosuccinate, sodium di-n-octylsulfosuccinate, polyoxyethylene nonylphenyl ether, and the like. The amount of these surfactants added is 0.5 to 5 mol per mol of the raw material phospholipid,
It is preferably 1 to 3 mol.
反応溶媒としては、下記の条件を満たすものであれば使
用できる。Any reaction solvent can be used as long as it satisfies the following conditions.
(a)原料リン脂質を臨界ミセル濃度以上の濃度で溶解
し得る。(A) The raw material phospholipid can be dissolved at a concentration equal to or higher than the critical micelle concentration.
(b)水をほとんど混和あるいは溶解しない。(B) Almost no water is mixed or dissolved.
(c)酵素活性に決定的な損失を与えない。(C) It does not give a decisive loss in enzyme activity.
すなわち、分子内に二重結合またはエーテル結合を有し
ていても構わない、アルキル基等の官能基を有していて
も構わない、炭素数5〜10の直鎖状または分岐鎖状また
は環状の炭化水素化合物もしくは炭素数1〜2のハロゲ
ン化炭化水素化合物あるいはそれらの混合物であり、例
としてn−ヘキサン、イソオクタン、ジエチルエーエ
ル、ジイソプロピルエーテル、シクロヘキサン、ベンゼ
ン、キシレン、クロロホルム、四塩化炭素、ジクロロエ
タンおよびこれらのうち二種以上の混合系があげられ
る。アルコール構造を持つ化合物は、ホスファチジル基
転移反応の受容体となるため、基質として用いる以外に
添加することはあまり好ましくない。That is, it may have a double bond or an ether bond in the molecule, may have a functional group such as an alkyl group, and has a linear or branched chain or cyclic group having 5 to 10 carbon atoms. Hydrocarbon compounds having 1 to 2 carbon atoms or a mixture thereof, and examples thereof include n-hexane, isooctane, diethyl ether, diisopropyl ether, cyclohexane, benzene, xylene, chloroform, carbon tetrachloride and dichloroethane. And mixed systems of two or more of these. A compound having an alcohol structure serves as an acceptor for a phosphatidyl group transfer reaction, and therefore it is not preferable to add it except for using it as a substrate.
ホスホリパーゼDとしては、ホスファチジル基転移活性
を有するものであれば、市販のものあるいは公知の方法
で調製したものを問わず使用できる。例として、ベーリ
ンガー・マンハイム社(Boehringer Mannheim GmbH)製
のキャベツ由来のホスホリパーゼD、東洋醸造(株)製
の微生物由来のホスホリパーゼD(PLDP)、公知の方法
〔一例としてケーツとサストリイ〔M.Kates and P.S.Sa
stry)の方法、“Methods in Enzymology"(J.M.Lowens
tein,ed.),vol.14,pp197−203,Achademic Press,New Y
ork(1969)〕により抽出し精製または部分精製した酵
素標品、または抽出した粗酵素があげられる。As the phospholipase D, any commercially available one or one prepared by a known method can be used as long as it has a phosphatidyl group transfer activity. As an example, cabbage-derived phospholipase D manufactured by Boehringer Mannheim GmbH, microbial-derived phospholipase D (PLDP) manufactured by Toyo Brewing Co., Ltd., a known method [as an example, Kates and Sustrii PSSa
stry), "Methods in Enzymology" (JMLowens
tein, ed.), vol.14, pp197−203, Achademic Press, New Y
ork (1969)] and purified or partially purified enzyme preparation, or extracted crude enzyme.
受容体としては、コリン、メタノール、エタノール、エ
タノールアミン、セリン、グリセロール、グルコース等
の従来ホスファチジル基転移反応の受容体として知られ
ている化合物のみならず、1−アミノ−2−プロパノー
ル、1−オルソメチルグルコシド、トレハロースをはじ
めとする従来ホスファチジル基転移反応の受容体とはな
らないとされていた糖類を含む一級または二級アルコー
ル構造を持つ化合物をも用いることができる。As the receptor, not only compounds such as choline, methanol, ethanol, ethanolamine, serine, glycerol and glucose which are conventionally known as receptors for phosphatidyl group transfer reaction, but also 1-amino-2-propanol and 1-ortho Compounds having a primary or secondary alcohol structure, including saccharides such as methyl glucoside and trehalose, which are conventionally not considered as an acceptor of the phosphatidyl group transfer reaction, can also be used.
酵素、受容体等を逆ミセル中に封入するには、原料リン
脂質を臨界ミセル濃度以上に溶かした有機溶媒中に、酵
素、受容体等の溶液を滴下し、ただちに振盪撹拌または
超音波処理するなどの公知の方法を用いることができ
る。To enclose enzymes, receptors, etc. in reverse micelles, a solution of enzymes, receptors, etc. is dropped into an organic solvent in which the raw material phospholipid is dissolved at a critical micelle concentration or higher, and immediately shaken or sonicated. A known method such as, for example, can be used.
逆ミセルを形成させると同時に、ホスファチジル基転移
反応時のPAの副生を抑えるためには、反応系中の水分含
量を原料リン脂質または界面活性剤1モルに対して6〜
15モルにする必要があり、好ましくは、8〜12モルで最
も良好な結果を得ることができる。At the same time as forming reverse micelles, in order to suppress the by-product of PA at the time of phosphatidyl group transfer reaction, the water content in the reaction system is 6 to 6 mol with respect to 1 mol of the raw material phospholipid or the surfactant.
It should be 15 moles, preferably 8-12 moles for best results.
反応温度は用いる酵素の至適温度であればよく、通常30
〜40℃の範囲である。好ましくは、逆ミセルを形成させ
てから酵素反応終了に至るまで一定に保つことにより逆
ミセルの安定性が向上する。ただし、用いる溶媒が低沸
点のものである場合等はこの限りではない。The reaction temperature may be the optimum temperature of the enzyme to be used, usually 30
It is in the range of ~ 40 ° C. Preferably, the stability of the reverse micelle is improved by keeping it constant from the formation of the reverse micelle to the end of the enzymatic reaction. However, this does not apply when the solvent used has a low boiling point.
反応時間は0.5〜36時間で、好ましくは4〜24時間であ
る。The reaction time is 0.5 to 36 hours, preferably 4 to 24 hours.
このようにして製造した任意の塩基を持つ目的リン脂質
は溶剤分画、ケイ酸またはシリカゲルクロマトグラフィ
ー、アルミナクロマトグラフィー、DEAE−セルロースク
ロマトグラフィー等の公知の手段を適宜用いることによ
り、容易に精製することができる。The target phospholipid having any base thus produced is easily purified by appropriately using known means such as solvent fractionation, silicic acid or silica gel chromatography, alumina chromatography, and DEAE-cellulose chromatography. be able to.
また、PAの生成が抑制されているため、未反応基質の回
収も容易に行うことができる。Further, since the production of PA is suppressed, the unreacted substrate can be easily recovered.
(発明の効果) 本発明の反応系を用いることにより、従来の反応系で見
られたようなPAの生成は抑制され、反応後の目的リン脂
質の分離精製が容易になった。(Effect of the Invention) By using the reaction system of the present invention, the production of PA as seen in the conventional reaction system is suppressed, and separation and purification of the target phospholipid after the reaction is facilitated.
また、従来の反応系では殆どあるいは全く得ることので
きなかった目的リン脂質をも製造することが可能となっ
た。Further, it has become possible to produce a target phospholipid that could hardly or hardly be obtained by the conventional reaction system.
(実施例) 以下、参考例、実施例、および比較例に基づいて本発明
を具体的に説明する。(Examples) Hereinafter, the present invention will be specifically described based on Reference Examples, Examples, and Comparative Examples.
なお、リン脂質の組成分析、純度検定は薄層クロマトグ
ラフィー(TLC)で行った。TLC板(メルク社製No.572
1)に脂質試料20〜100μgを直径3〜5mmにスポット
し、クロロホルム−メタノール−水(120:70:5)または
クロロホルム−アセトン−酢酸−メタノール−水(50:2
0:15:10:5)で展開した。検出にはジットマー試薬、50
%硫酸、ニンヒドリン試薬またはアンスロン試薬を目的
に応じて使用した。定量的な測定にはジットマー試薬で
発色したものを高速薄層クロマトスキャナー(島津製作
所製CS−920型)で測定した。The composition analysis and purity test of phospholipids were performed by thin layer chromatography (TLC). TLC plate (Merck No.572
A lipid sample (20 to 100 μg) was spotted on 1 to 3 to 5 mm in diameter, and chloroform-methanol-water (120: 70: 5) or chloroform-acetone-acetic acid-methanol-water (50: 2) was added.
It was deployed at 0: 15: 10: 5). Detecter Reagent, 50 for detection
% Sulfuric acid, ninhydrin reagent or anthrone reagent was used depending on the purpose. For quantitative measurement, the color developed with the Zitmer reagent was measured with a high-speed thin-layer chromatography scanner (CS-920 manufactured by Shimadzu Corporation).
参考例1 大豆PCおよびPEをパルダン(Von H.Pardun)の方法〔Fe
tte Seifen Anstrichmitte86,(2)55−62(1984)〕
により分離、分画した。Reference Example 1 Soybean PC and PE were paldan (Von H. Pardun) method [Fe
tte Seifen Anstrichmitte 86 , (2) 55-62 (1984)]
Were separated and fractionated by.
市販脱脂大豆レシチン粉末(PC24%、PE21%、ホスファ
チジルイノシトール14%、PA8%)20gをイソプロパノー
ル−メタノール−水(50:45:5)100mlに分散し、40℃で
加熱撹拌し溶解した。撹拌しながら20℃まで冷却し、20
℃に1時間保った。不溶物を20℃に保ったまま遠心分離
またはガラスフィルターで減圧濾過した。集めた上清を
減圧下で乾固し、PCおよびPE濃縮物(PC68%、PE17%、
PA7%、PSは含まない)9.7gを得た。20 g of commercially available defatted soybean lecithin powder (PC24%, PE21%, phosphatidylinositol 14%, PA8%) was dispersed in 100 ml of isopropanol-methanol-water (50: 45: 5) and dissolved by heating with stirring at 40 ° C. Cool to 20 ℃ with stirring and
Hold at ℃ for 1 hour. The insoluble matter was centrifuged or vacuum-filtered with a glass filter while keeping the insoluble matter at 20 ° C. The collected supernatant was dried under reduced pressure to obtain PC and PE concentrates (PC68%, PE17%,
PA7%, PS not included) 9.7 g was obtained.
参考例2 牛脳からリーズ(M.Lees)の方法〔“Methods in Enzym
ology"(S.P.Colowick and N.O.Kaplan ed.),vol.3,pp
328,Achademic Press,New York(1957)〕により粗セフ
ァリンを抽出し、DEAE−セルロースカラムクロマトグラ
フィーで精製した。Reference Example 2 Beef brain to M. Lees ["Methods in Enzym
ology "(SPColowick and NOKaplan ed.), vol.3, pp
328, Achademic Press, New York (1957)], and crude cephalin was extracted and purified by DEAE-cellulose column chromatography.
近在の屠殺場で入手した新鮮な牛脳の脳膜および血管を
取り除いたもの300gを1.2のアセトン中でホモジナイ
ズし、抽出した。濾過残渣をもう一度1.2のアセトン
で抽出する。濾過残渣を1.2のエタノールで抽出す
る。濾過残渣を同様にして1.2の石油エーテルで2回
抽出し、抽出液を集めて減圧乾固し、粗セファリン画分
3.9gを得た。300 g of fresh bovine brain debris and blood vessels from a local slaughterhouse were homogenized in 1.2 acetone and extracted. The filter residue is extracted once again with 1.2 acetone. The filter residue is extracted with 1.2 ethanol. The filtration residue was extracted twice with 1.2 petroleum ether in the same manner, and the extracts were collected and dried under reduced pressure to give a crude sephaline fraction.
3.9 g was obtained.
このものをクロロホルムに溶解し、酢酸型に調製したDE
AE−セルロースカラム(ワットマン社製DE32、径2.5cm
×20cm)を用いて分画した。クロロホルム−メタノール
(1:4)1でカラムを洗浄後、酢酸750mlで溶出した画
分を集めた。酢酸溶出画分に等容のクロロホルムを加
え、2倍容の水で4回洗浄した。クロロホルム層を減圧
乾固し、PS(PS98%)0.8gを得た。This product was dissolved in chloroform to prepare DE
AE-Cellulose column (Whatman DE32, diameter 2.5 cm
X 20 cm) was used for fractionation. After washing the column with chloroform-methanol (1: 4) 1, fractions eluted with 750 ml of acetic acid were collected. An equal volume of chloroform was added to the fraction eluted with acetic acid, and the fraction was washed 4 times with 2 volumes of water. The chloroform layer was dried under reduced pressure to obtain 0.8 g of PS (PS98%).
参考例3 市販のジオクチルスルホコハク酸ナトリウムを精製し
た。Reference Example 3 Commercially available sodium dioctylsulfosuccinate was purified.
ジオクチルスルホコハク酸ナトリウム(日本油脂株式会
社製、商品名ラピゾールB−90)の50%メタノール溶液
100mlを4℃で3時間静置後、4℃で2,000×g、15分間
遠心分離し沈殿を除去した。50% methanol solution of sodium dioctyl sulfosuccinate (Nippon Yushi Co., Ltd., trade name Lapizole B-90)
100 ml was left standing at 4 ° C. for 3 hours and then centrifuged at 4 ° C. at 2,000 × g for 15 minutes to remove the precipitate.
上清に特級活性炭(和光純薬(株)製)5gを加え、18時
間穏やかに撹拌した。活性炭を濾別し、メタノールを溜
去した。5 g of special grade activated carbon (manufactured by Wako Pure Chemical Industries, Ltd.) was added to the supernatant and gently stirred for 18 hours. Activated carbon was filtered off and methanol was distilled off.
乾固物を五酸化リンの入った減圧デシケーター中で一昼
夜以上乾燥したものを精製ジオクチルスルホコハク酸ナ
トリウムとして用いた。The dried product was dried in a vacuum desiccator containing phosphorus pentoxide for one day or more and used as purified sodium dioctylsulfosuccinate.
参考例4 前出のケーツとサストリイ(M.Kates and P.S.Sastry)
の方法に従ってキャベツ可溶画分からホスホリパーゼD
を部分精製した。Reference Example 4 M.Kates and PSSastry
From cabbage soluble fraction according to the method of
Was partially purified.
近在の農家から入手した新鮮なキャベツの内側の葉を水
洗後細断し、100gに水200mlを加え、氷冷下で5分間ホ
モジナイズした。5重にしたガーゼで濾過した濾液を4
℃で12,000×g、30分間遠心分離し、上清190mlを得
た。この上清を55℃、5分間熱処理後、直ちに氷冷し
た。4℃で12,000×g、30分間遠心分離し、上清175ml
を得た。The inner leaf of fresh cabbage obtained from a nearby farm was washed with water, then shredded, 200 ml of water was added to 100 g, and the mixture was homogenized for 5 minutes under ice cooling. The filtrate obtained by filtering with 5 layers of gauze is 4
Centrifugation at 12,000 xg for 30 minutes at 190C gave 190 ml of supernatant. This supernatant was heat-treated at 55 ° C. for 5 minutes and immediately cooled with ice. Centrifuge at 12,000 xg for 30 minutes at 4 ℃, and supernatant 175ml
Got
−15℃に冷却したアセトン350mlを撹拌しながら少しず
つ加え、10分間静置後4℃で12,000×g、30分間遠心分
離して沈殿を集めた。Acetone (350 ml) cooled to −15 ° C. was added little by little with stirring, and the mixture was allowed to stand for 10 minutes and then centrifuged at 4 ° C. at 12,000 × g for 30 minutes to collect a precipitate.
沈殿を15mlの50mM酢酸緩衝液pH5.6に溶かし、4℃で同
じ緩衝液500mlに対し3回透析した。The precipitate was dissolved in 15 ml of 50 mM acetate buffer pH 5.6 and dialyzed 3 times against 500 ml of the same buffer at 4 ° C.
不溶物を4℃で10,000×g、15分間遠心分離したものを
キャベツ部分精製ホスホリパーゼDとして用いた。The insoluble matter was centrifuged at 10,000 xg for 15 minutes at 4 ° C and used as partially purified cabbage phospholipase D.
なお、この酵素液には検出可能量のリン脂質は含まれて
いないことを確認した。It was confirmed that this enzyme solution did not contain a detectable amount of phospholipid.
実施例1 L−セリン1.5M、キャベツホスホリパーゼD(ベーリン
ガー・マンハイム社製)7mg/ml、塩化カルシウム・二水
塩10mMを0.5mlの5mM酢酸緩衝液pH5.6に溶かし、水相と
した。参考例1で得た大豆PCおよびPEの濃縮物1.5gを乾
燥したジイソプロピルエーテル40mlに溶かし、有機相と
した。Example 1 L-serine 1.5M, cabbage phospholipase D (Boehringer Mannheim) 7 mg / ml, and 10 mM calcium chloride dihydrate were dissolved in 0.5 ml of 5 mM acetate buffer pH 5.6 to obtain an aqueous phase. 1.5 g of the soybean PC and PE concentrate obtained in Reference Example 1 was dissolved in 40 ml of dried diisopropyl ether to obtain an organic phase.
有機相を35℃に保ち、NS100−2U型超音波洗浄機(出力1
00W、日本精機製作所製)で超音波処理しながら水相0.3
5mlを滴下し、更に1分間超音波処理し、ほぼ透明な逆
ミセル液を得た。Keep the organic phase at 35 ℃, NS100-2U type ultrasonic cleaner (output 1
00W, manufactured by Nippon Seiki Seisakusho, Ltd.), water phase 0.3 while sonicating
5 ml was added dropwise and sonication was further performed for 1 minute to obtain an almost transparent reverse micelle solution.
このものを35℃、12時間、15rpmで往復振盪し、反応さ
せた。This was reacted by shaking back and forth at 35 ° C. for 12 hours at 15 rpm.
反応混液の一部を取り、直接TLCで分析したところ、PC4
8%、PE14%、PA11%で、標準PSとRfが一致し、ジット
マー試薬およびニンヒドリン試薬に陽性を示すことから
PSと同定した生成物24%を含んでいた。When a part of the reaction mixture was taken and directly analyzed by TLC, PC4
8%, PE14%, PA11%, the standard PS and Rf match, and it is positive for the gitmer reagent and ninhydrin reagent.
It contained 24% of the product identified as PS.
反応混液をそのまま酢酸型に調製したDEAE−セルロース
カラム(ワットマン社製 DE32、径2.5×20cm)を用いて
分画した。The reaction mixture was directly fractionated using a DEAE-cellulose column (DE32 manufactured by Whatman, diameter 2.5 × 20 cm) prepared in the form of acetic acid.
カラムをクロロホルム−メタノール(1:4)500mlで溶出
し、減圧乾固して未反応基質(PC73%、PE27%)を回収
した。The column was eluted with 500 ml of chloroform-methanol (1: 4) and dried under reduced pressure to recover unreacted substrate (PC73%, PE27%).
更にカラムを酢酸400mlで溶出した。酢酸溶出画分を集
め、等容のクロロホルムを加え、2倍容の水で4回洗浄
した。クロロホルム層を減圧乾固し、PS(PS98%)294m
gを回収した。Further, the column was eluted with 400 ml of acetic acid. The acetic acid elution fractions were collected, an equal volume of chloroform was added, and the mixture was washed 4 times with 2 volumes of water. Chloroform layer was dried under reduced pressure, PS (PS98%) 294m
g was recovered.
実施例2 市販水素添加卵黄レシチン(PS99%)40mgを溶かしたイ
ソオクタン1mlを有機相として、38℃で実施例1と同様
にして、塩酸でpH5.7に調整した1−アミノ−2−プロ
パノール1.5M、キャベツホスホリパーゼD(ベーリンガ
ー・マンハイム社製)7mg/ml、塩化カルシウム・二水塩
10mMからなる水相11μを滴下し、逆ミセルを形成させ
た。Example 2 1-amino-2-propanol 1.5 adjusted to pH 5.7 with hydrochloric acid in the same manner as in Example 1 at 38 ° C. using 1 ml of isooctane in which 40 mg of commercially available hydrogenated egg yolk lecithin (PS99%) was dissolved as an organic phase. M, cabbage phospholipase D (Boehringer Mannheim) 7 mg / ml, calcium chloride dihydrate
A reverse micelle was formed by dropwise addition of 11 μ of an aqueous phase consisting of 10 mM.
このものを38℃、8時間、15rpmで往復振盪し、反応さ
せた。This product was reacted by shaking back and forth at 38 ° C. for 8 hours at 15 rpm.
反応混液の一部を取り、直接TLCで分析したところ、PC6
2%、PA5%で、標準PEとRfが近接しジットマー試薬およ
びニンヒドリン試薬に陽性を示すことから1−アミノ−
2−プロパノールにホスファチジル基が導入された目的
リン脂質と判定した生成物24%を含んでいた。A part of the reaction mixture was taken and directly analyzed by TLC.
At 2% and 5% PA, the standard PE and Rf were close to each other and showed positive for the Jitmer reagent and ninhydrin reagent, so 1-amino-
The product contained 24% of the product judged to be a target phospholipid having a phosphatidyl group introduced into 2-propanol.
実施例3 参考例2で得た牛脳PS(PS98%)40mgを溶かしたシクロ
ヘキサン1mlを有機相として、38℃で実施例1と同様に
して、グリセリン1.5M、キャベツホスホリパーゼD(ベ
ーリンガー・マンハイム社製)7mg/ml、塩化カルシウム
・二水塩10mM、5mM酢酸緩衝液pH5.6からなる水相9μ
を滴下し、逆ミセルを形成させた。Example 3 Using 1 ml of cyclohexane in which 40 mg of bovine brain PS (PS98%) obtained in Reference Example 2 was dissolved as an organic phase, and at 38 ° C., glycerin 1.5M and cabbage phospholipase D (Boehringer Mannheim) 9 mg of aqueous phase consisting of 7 mg / ml, calcium chloride / dihydrate 10 mM, 5 mM acetate buffer pH 5.6
Was added dropwise to form reverse micelles.
このものを38℃、12時間、15rpmで往復振盪し、反応さ
せた。This was reacted by shaking back and forth at 38 ° C. for 12 hours at 15 rpm.
反応混液の一部を取り、直接TLCで分析したところ、PS7
0%、PA3%で、標準PGとRfが一致し、ジットマー試薬に
陽性を示すことからPGと同定した生成物25%を含んでい
た。A part of the reaction mixture was taken and directly analyzed by TLC.
The product contained 25% of the product identified as PG because the Rf was in agreement with the standard PG at 0% and PA3% and was positive for the Zitmer reagent.
実施例4 市販ジパルミトイルPC100mgを溶かしたベンゼン2.5mlを
有機相として、35℃で実施例1と同様にして1−オルソ
メチルグルコシド1.5M、ホスホリパーゼD(東洋醸造
(株)製PLDP)1mg/ml、5mM酢酸緩衝液pH5.6からなる水
相20μを滴下し、逆ミセルを形成させた。Example 4 Using 2.5 ml of benzene in which 100 mg of commercially available dipalmitoyl PC was dissolved as an organic phase, 1-orthomethyl glucoside 1.5M and phospholipase D (PLDP manufactured by Toyo Brewery Co., Ltd.) 1 mg / ml at 35 ° C. in the same manner as in Example 1. Then, 20 μm of an aqueous phase consisting of 5 mM acetate buffer (pH 5.6) was added dropwise to form reverse micelles.
このものを35℃、12時間、15rpmで往復振盪し、反応さ
せた。This was reacted by shaking back and forth at 35 ° C. for 12 hours at 15 rpm.
反応混液の一部を取り、直接TLCで分析したところ、PC7
4%、PA4%で、未同定リン脂質19%を含んでいた。A part of the reaction mixture was taken and directly analyzed by TLC.
It contained 4% and 4% PA, and 19% unidentified phospholipids.
反応混液を直接、No.5745分取用TLCプレート(メルク社
製)を用い、クロロホルム−メタノール−水(120:70:
5)を展開溶媒として分画、分取し、未同定リン脂質16m
gを得た。The reaction mixture was directly used for No.5745 preparative TLC plate (manufactured by Merck) and chloroform-methanol-water (120: 70:
Fractionation and fractionation using 5) as developing solvent, unidentified phospholipid 16m
got g.
このリン脂質をJMS−DX303型質量分析装置(日本電子
(株)製)を用い、下記条件にて分析したところ、陽イ
オン側の親ピークがm/e847、陰イオン側の親ピークがm/
e823であった。When this phospholipid was analyzed under the following conditions using a JMS-DX303 mass spectrometer (manufactured by JEOL Ltd.), the parent peak on the cation side was m / e847 and the parent peak on the anion side was m / e847.
It was e823.
測定条件 イオン化法:FAB法 衝撃ガス:Xe 一時イオン加速電圧:6kV フィラメント電流:20mA 検出器:オンバーション・ダイノード 押し出し電圧:15kV マトリクス:トリエタノールアミン(陽イオンの場合塩
化ナトリウム添加) データ処理:JMA−DA5000 これらの値は1−オルソメチルグルコシドにホスファチ
ジル基が導入されたと仮定した分子量(824)の各々ナ
トリウム塩(分子量824+23)および陰イオン(分子量8
24−1)と一致したことから、目的リン脂質であると同
定した。Measurement conditions Ionization method: FAB method Impact gas: Xe Temporary ion acceleration voltage: 6kV Filament current: 20mA Detector: Onversion dynode Extrusion voltage: 15kV Matrix: Triethanolamine (sodium chloride added for cation) Data processing: JMA-DA5000 These values are sodium salt (molecular weight 824 + 23) and anion (molecular weight 8), which are assumed to have a phosphatidyl group introduced into 1-orthomethylglucoside.
Since it coincided with 24-1), it was identified as a target phospholipid.
実施例5 市販ジパルミトイルPC100mgを溶かしたクロロホルム−
イソオクタン(35:65)2.5mlを有機相として、35℃で実
施例1と同様にして、トレハロース1.5M、ホスホリパー
ゼD(東洋醸造(株)製PLDP)1mg/ml、5mM酢酸緩衝液p
H5.6からなる水相17μを滴下し、逆ミセルを形成させ
た。Example 5 Chloroform in which 100 mg of commercially available dipalmitoyl PC was dissolved
2.5 ml of isooctane (35:65) was used as an organic phase, and trehalose 1.5M, phospholipase D (PLDP manufactured by Toyo Brewery Co., Ltd.) 1 mg / ml, 5 mM acetate buffer p at 35 ° C in the same manner as in Example 1.
A reverse micelle was formed by dropping 17 μ of an aqueous phase containing H5.6.
このものを35℃、12時間、15rpmで往復振盪し、反応さ
せた。This was reacted by shaking back and forth at 35 ° C. for 12 hours at 15 rpm.
反応混液の一部を取り、直接TLCで分析したところ、PC7
6%、PA5%で、ジットマー試薬およびアンスロン試薬に
同時に陽性を示すことから、トレハロースにホスファチ
ジル基が導入された目的リン脂質であると判定したリン
脂質17%を含んでいた。A part of the reaction mixture was taken and directly analyzed by TLC.
Since 6% and 5% PA simultaneously showed positive results for the gitmer reagent and the anthrone reagent, 17% of the phospholipids judged to be the target phospholipid having a phosphatidyl group introduced into trehalose were included.
反応混液を実施例4と同様にして分画分取して得たリン
脂質16mgを実施例4と同様にして質量分析を行ったとこ
ろ、陽イオン側親ピークm/e995、陰イオン側親ピークm/
e971で、計算分子量(972)の各々ナトリウム塩(分子
量972+23)、陰イオン(分子量972−1)と一致したこ
とから、目的リン脂質であると同定した。16 mg of the phospholipid obtained by fractionating the reaction mixture in the same manner as in Example 4 was subjected to mass spectrometry in the same manner as in Example 4, and the cation side parent peak m / e995 and the anion side parent peak were obtained. m /
At e971, it was identified as the target phospholipid because it coincided with the calculated sodium (972) sodium salt (molecular weight 972 + 23) and anion (molecular weight 972-1).
実施例6 市販ジオクチルPC100mg、参考例3で得た精製ジオクチ
ルスルホコハク酸ナトリムウム90mgを溶かしたn−ヘキ
サン3mlを有機相として、37℃で実施例1と同様にし
て、塩酸でpH6.0に調整した1.5Mエタノールアミンに1mg
/mlのホスホリパーゼD(東洋醸造(株)製PLDP)を溶
かしたもの36μを水相として滴下し、逆ミセルを形成
させた。Example 6 3 mg of n-hexane in which 100 mg of commercially available dioctyl PC and 90 mg of purified dioctyl sulfosuccinate sodium sodium obtained in Reference Example 3 were dissolved as an organic phase, and the pH was adjusted to 6.0 with hydrochloric acid at 37 ° C. in the same manner as in Example 1. 1M in 1.5M ethanolamine
A solution of phospholipase D (/ ml PLDP manufactured by Toyo Shuzo Co., Ltd.) in an amount of 36 μm was added dropwise as an aqueous phase to form reverse micelles.
このものを37℃、10時間、15rpmで往復振盪し、反応さ
せた。This was shaken back and forth at 37 ° C. for 10 hours at 15 rpm to react.
反応混液の一部を取り、直接TLCで分析したところ、PC7
1%、PA7%で、標準PEに近いRf値を持ち、ジットマー試
薬およびニンヒドリン試薬に同時に陽性を示すことか
ら、目的リン脂質であると判定したリン脂質22%を含ん
でいた。A part of the reaction mixture was taken and directly analyzed by TLC.
It contained 22% of phospholipids judged to be the target phospholipids, since they had Rf values close to those of standard PE at 1% and PA 7%, and showed positive positivity for jidmer reagent and ninhydrin reagent at the same time.
実施例7 市販1−ステアロイルリゾPC200mg、ラウリル硫酸ナト
リウム(和光純薬(株)製、生化学用)100mgを溶かし
たジクロロメタン−イソオクタン(3:7)5mlを有機相と
し、35℃で実施例1と同様にして、参考例4で得たキャ
ベツ部分精製酵素液に1.5Mのグリセリン、塩化カルシウ
ム・二水塩10mMを溶かしたもの65μを水相として滴下
し、逆ミセルを形成させた。Example 7 5 ml of dichloromethane-isooctane (3: 7) in which 200 mg of commercially available 1-stearoyl lyso PC and 100 mg of sodium lauryl sulfate (manufactured by Wako Pure Chemical Industries, Ltd., for biochemistry) were dissolved were used as an organic phase, and Example 1 was used at 35 ° C. In the same manner as above, 65 μ of a solution of 1.5 M glycerin and 10 mM of calcium chloride / dihydrate in the cabbage partially purified enzyme solution obtained in Reference Example 4 was dropped as an aqueous phase to form reverse micelles.
このものを35℃、15時間、15rpmで往復振盪し、反応さ
せた。This was reacted by shaking back and forth at 35 ° C. for 15 hours at 15 rpm.
反応混液を直接、酢酸型に調製したDEAE−セルロースカ
ラム(ワットマン社製DE52、径1.8×5cm)を用いて分画
した。クロロホルム−メタノール(1:4)100mlでカラム
を洗浄後、50mM酢酸アンモニウムを含むクロロホルム−
メタノール(1:4)100mlで溶出した画分を集めた。酢酸
溶出画分に、等容のクロロホルムを加え、2倍容の水で
4回洗浄した。The reaction mixture was directly fractionated using a DEAE-cellulose column (DE52 manufactured by Whatman, diameter 1.8 × 5 cm) prepared in the form of acetic acid. After washing the column with 100 ml of chloroform-methanol (1: 4), chloroform containing 50 mM ammonium acetate-
Fractions eluted with 100 ml of methanol (1: 4) were collected. An equal volume of chloroform was added to the fraction eluted with acetic acid, and the fraction was washed 4 times with 2 volumes of water.
クロロホルム層を減圧乾固して得られたリン脂質26.7mg
を実施例4と同様にして質量分析を行ったところ、陽イ
オン側親ピークm/e534、陰イオン側親ピークm/e511で、
計算分子量(512)の各々ナトリウム塩(分子量512+2
3)、陰イオン(分子量512−1)と一致したことから、
目的とする1−ステアロイルリゾPGであると同定した。26.7 mg of phospholipid obtained by drying the chloroform layer under reduced pressure
Was subjected to mass spectrometry in the same manner as in Example 4 to find that the cation side parent peak m / e534 and the anion side parent peak m / e511
Calculated molecular weight (512) each sodium salt (molecular weight 512 + 2
3), since it coincided with the anion (molecular weight 512-1),
It was identified as the desired 1-stearoyl lyso PG.
比較例1 従来の反応系で、実施例1とできるだけ近い条件で反応
を行った。Comparative Example 1 The reaction was carried out in the conventional reaction system under the conditions as close as possible to Example 1.
L−セリン200mM、塩化カルシウム40mM、ホスホリパー
ゼD(ベーリンガー・マンハイム社製)2.5mgを含むpH
5.6の50mM酢酸緩衝液2.5mlと、参考例1で得た大豆PCお
よびPE濃縮物40mgを溶かしたジイソプロピルエーテル5m
lを37℃、500rpmで撹拌した。PH containing L-serine 200 mM, calcium chloride 40 mM, and phospholipase D (Boehringer Mannheim) 2.5 mg
5 ml of diisopropyl ether in which 2.5 ml of 50 mM acetate buffer of 5.6 and 40 mg of the soybean PC and PE concentrate obtained in Reference Example 1 were dissolved
l was stirred at 37 ° C. and 500 rpm.
同一のもの5検体を平行して各1、2、4、12時間反応
させた。反応後、5mlのジエチルエーテルで3回脂質を
抽出し、リン脂質組成を分析した。結果を下表に示す。Five identical samples were reacted in parallel for 1, 2, 4, and 12 hours, respectively. After the reaction, the lipid was extracted three times with 5 ml of diethyl ether, and the phospholipid composition was analyzed. The results are shown in the table below.
比較例2 従来の反応系で、実施例4とできるだけ近い条件で反応
を行った。 Comparative Example 2 The reaction was carried out in the conventional reaction system under the conditions as close as possible to Example 4.
1−オルソメチルグルコシド1.5M、ホスホリパーゼD
(東洋醸造(株)製PLDP)20μgを溶かしたpH5.6の50m
M酢酸緩衝液2.5mlと、ジパルミトイルPC100mgを溶かし
たベンゼン2.5mlを35℃、500rpmで撹拌し、反応させ
た。1-Orthomethyl glucoside 1.5M, phospholipase D
(PLDP made by Toyo Brewery Co., Ltd.) 50 μm with 20 μg dissolved in pH 5.6
2.5 ml of M acetate buffer and 2.5 ml of benzene in which 100 mg of dipalmitoyl PC was dissolved were stirred at 35 ° C. and 500 rpm to cause a reaction.
比較例1と同様にして経時的に分析したが、実施例4で
認められた目的リン脂質に相当するスポットがTLC上に
認められず、16時間反応した時点で基質が完全に分解さ
れたため、分析を打ち切った。When analyzed in the same manner as in Comparative Example 1 over time, no spot corresponding to the target phospholipid found in Example 4 was found on TLC, and the substrate was completely decomposed at the time of reaction for 16 hours. The analysis was terminated.
比較例3 従来の反応系で、実施例5とできるだけ近い条件で反応
を行った。Comparative Example 3 The reaction was carried out in the conventional reaction system under the conditions as close as possible to Example 5.
トレハロース1.5M、ホスホリパーゼD(東洋醸造(株)
製PLDP)20μgを溶かしたpH5.6の50mM酢酸緩衝液2.5ml
と、ジパルミトイルPC100mgを溶かしたクロロホルム−
イソオクタン(35:65)2.5mlを35℃、500rpmで撹拌し、
反応させた。Trehalose 1.5M, phospholipase D (Toyo Brewing Co., Ltd.)
2.5 ml of 50 mM acetate buffer of pH 5.6 containing 20 μg of PLDP
And chloroform containing 100 mg of dipalmitoyl PC dissolved in
2.5 ml of isooctane (35:65) was stirred at 35 ° C and 500 rpm,
It was made to react.
比較例1と同様にして経時的に分析したが、実施例5で
認められた目的リン脂質に相当するスポットがTLC上に
認められず、16時間反応した時点で基質が完全に分解さ
れたため、分析を打ち切った。When analyzed over time in the same manner as in Comparative Example 1, no spot corresponding to the target phospholipid found in Example 5 was found on TLC, and the substrate was completely decomposed at the time of reaction for 16 hours, The analysis was terminated.
Claims (3)
にあたり、原料リン脂質を溶解した有機溶媒中に、水酸
基を持つ受容体およびホスホリパーゼDを含む水相を逆
ミセル中に封入した形態で添加して反応を行うことを特
徴とする酵素によるリン脂質の製造方法。1. A method for producing a phospholipid having a converted base structure, wherein an aqueous phase containing a receptor having a hydroxyl group and phospholipase D is encapsulated in a reverse micelle in an organic solvent in which a raw material phospholipid is dissolved. A method for producing a phospholipid by an enzyme, which comprises adding and performing a reaction.
面活性剤として原料リン脂質自体を利用する特許請求の
範囲第1項記載の製造方法。2. The production method according to claim 1, wherein the reverse micelles are formed from a surfactant, and the raw material phospholipid itself is used as the surfactant.
アミノ−2−プロパノール、1−オルソメチル−グルコ
シド、グリセロール、トレハロースのいずれかである特
許請求の範囲第1項記載の製造方法。3. Receptor is serine, ethanolamine, 1-
The production method according to claim 1, which is any one of amino-2-propanol, 1-orthomethyl-glucoside, glycerol and trehalose.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP18002586A JPH0716426B2 (en) | 1986-08-01 | 1986-08-01 | Method for producing phospholipid by enzyme |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP18002586A JPH0716426B2 (en) | 1986-08-01 | 1986-08-01 | Method for producing phospholipid by enzyme |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS6336792A JPS6336792A (en) | 1988-02-17 |
| JPH0716426B2 true JPH0716426B2 (en) | 1995-03-01 |
Family
ID=16076149
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP18002586A Expired - Fee Related JPH0716426B2 (en) | 1986-08-01 | 1986-08-01 | Method for producing phospholipid by enzyme |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH0716426B2 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100820657B1 (en) * | 2000-08-09 | 2008-04-10 | 가부시키가이샤 야쿠루트 혼샤 | Preparation of Phospholipids |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2170079T3 (en) * | 1994-06-17 | 2002-08-01 | Nestle Sa | INCORPORATION, IN A LIPID, OF A HYDROSOLUBLE ACTIVE PRINCIPLE. |
| US6017558A (en) * | 1994-06-17 | 2000-01-25 | Nestec S.A. | Incorporation of a water-soluble active principle in a lipid |
| JP3791951B2 (en) * | 1995-11-08 | 2006-06-28 | 株式会社ヤクルト本社 | Method for producing oil and fat composition containing polyunsaturated fatty acid-containing phosphatidylserine |
| US5700668A (en) † | 1995-12-08 | 1997-12-23 | Italfarmaco Sud S.P.A. | Process for the industrial preparation of phosphatidylserine |
| JP3478367B2 (en) * | 1997-02-18 | 2003-12-15 | 松下電器産業株式会社 | Outdoor unit for separation type air conditioner |
| KR100442538B1 (en) * | 2001-05-07 | 2004-07-30 | 주식회사 두산 | Method for producing phosphatidylserine and lysophosphatidylserine in organic solvent |
| KR20030084200A (en) * | 2002-04-25 | 2003-11-01 | 주식회사 두산 | Method for producing phosphatidylethanolamine and lysophosphatidylethanolamine using non-organic solvent system and a water-soluble composition comprising the lysophosphatidylethanolamine produced by the method |
| JP7357471B2 (en) * | 2019-06-13 | 2023-10-06 | キユーピー株式会社 | Phospholipid purification method |
-
1986
- 1986-08-01 JP JP18002586A patent/JPH0716426B2/en not_active Expired - Fee Related
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100820657B1 (en) * | 2000-08-09 | 2008-04-10 | 가부시키가이샤 야쿠루트 혼샤 | Preparation of Phospholipids |
| US7695944B2 (en) | 2000-08-09 | 2010-04-13 | Kabushiki Kaisha Yakult Honsha | Method for producing phosholipid |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6336792A (en) | 1988-02-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6492146B1 (en) | Process for the preparation of phosphatidylserines | |
| Ulsamer et al. | Plasma and phagosome membranes of Acanthamoeba castellanii | |
| EP0125039B1 (en) | Enzymatic production of phospholipid-saccharide derivatives | |
| EP0922707B2 (en) | A process for the purification of phosphatidylserine | |
| US5183750A (en) | Processes for the production of phosphatidic acid | |
| US20040235119A1 (en) | Method for the production of phospholipids | |
| EP0122151A2 (en) | Production of primary or secondary alcohol derivatives of phospholipids by the enzymatic technique | |
| Juneja et al. | Enzymatic method of increasing phosphatidylcholine content of lecithin | |
| JP3690686B2 (en) | Method for producing lysophosphatidylcholine | |
| JPH0716426B2 (en) | Method for producing phospholipid by enzyme | |
| CN1402794A (en) | The preparation method of lysophosphatidylethanolamine | |
| JPS6336791A (en) | Production of phospholipid by enzyme | |
| Paltauf et al. | [12] Preparation of alkyl ether and vinyl ether substrates for phospholipases | |
| US6660504B2 (en) | Process for exchanging bases in phospholipids | |
| US5100787A (en) | Method for preparing highly purified phosphatidylinositol | |
| JP2001178489A (en) | Method of producing cyclic phosphatidic acid | |
| WO1989004314A1 (en) | Anti-viral compounds and compositions containing them | |
| Marinetti et al. | Cross-linking of phospholipid neighbors in the erythrocyte membrane | |
| Batrakov et al. | Steric analysis of glycerophospholipids by circular dichroism. Stereospecifity of phospholipase D catalyzed transesterification | |
| US6924130B1 (en) | Enzymatic transesterification or hydrolysis of phospholipids in aqueous media | |
| JP2011211921A (en) | Method for producing cyclic phosphatidic acid | |
| KR100225669B1 (en) | Production method of high purity phospholipid using enzyme | |
| JPS6188886A (en) | Preparation of phospholipid long-chain alcohol derivative by enzymatic process | |
| JP2683590B2 (en) | Method for producing enzyme-converted phospholipid | |
| JP2799621B2 (en) | Method for producing phospholipase D |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| LAPS | Cancellation because of no payment of annual fees |